Methamphetamine enhances HIV infection of macrophages

American Journal of Pathology

Volumn 172, Issue 6, 2008, Pages 1617-1624

  Liang, Hao ^a,b   Wang, Xu ^a   Chen, Hui ^a,b   Song, Li ^a   Ye, Li ^a   Wang, Shi Hong ^a,c   Wang, Yan Jian ^a   Zhou, Lin ^a,d   Ho, Wen Zhe ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b GUANGXI MEDICAL UNIVERSITY   (China)

^c RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^d HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

8 BROMO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ALPHA INTERFERON; METHAMPHETAMINE; STAT1 PROTEIN;

ARTICLE; CONTROLLED STUDY; DRUG ABUSE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOGENESIS; IMMUNOTOXICITY; INTERFERON PRODUCTION; MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS INFECTIVITY;

EID: 44849111561     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2008.070971     Document Type: Article

References (55)

1. Colfax G, Shoptaw S: The methamphetamine epidemic: implications for HIV prevention and treatment. Curr HIV/AIDS Rep 2005, 2:194-199
2. Rawson RA, Anglin MD, Ling W: Will the methamphetamine problem go away? J Addict Dis 2002, 21:5-19
3. Semple SJ, Patterson TL, Grant I: Motivations associated with methamphetamine use among HIV+ men who have sex with men. J Subst Abuse Treat 2002, 22:149-156
4. Copeland AL, Sorensen JL: Differences between methamphetamine users and cocaine users in treatment. Drug Alcohol Depend 2001, 62:91-95
5. Crofts N, Hopper JL, Milner R, Breschkin AM, Bowden DS, Locarnini SA: Blood-borne virus infections among Australian injecting drug users: implications for spread of HIV. Eur J Epidemiol 1994, 10:687-694
6. Harris NV, Thiede H, McGough JP, Gordon D: Risk factors for HIV infection among injection drug users: results of blinded surveys in drug treatment centers, King County, Washington 1988-1991. J Acquir Immune Defic Syndr 1993, 6:1275-1282
7. HIV & drugs: meth use develops stronger link to HIV risk. AIDS Policy Law 2005, 20:5
8. Boddiger D: Metamphetamine use linked to rising HIV transmission. Lancet 2005, 365:1217-1218
9. Volkow ND, Wang GJ, Fowler JS, Telang F, Jayne M, Wong C: Stimulant-induced enhanced sexual desire as a potential contributing factor in HIV transmission. Am J Psychiatry 2007, 164:157-160
10. Frosch D, Shoptaw S, Huber A, Rawson RA, Ling W: Sexual HIV risk among gay and bisexual male methamphetamine abusers. J Subst Abuse Treat 1996, 13:483-486
11. Halkitis PN, Fischgrund BN, Parsons JT: Explanations for methamphetamine use among gay and bisexual men in New York City. Subst Use Misuse 2005, 40:1331-1345
12. Urbina A, Jones K: Crystal methamphetamine, its analogues, and HIV infection: medical and psychiatric aspects of a new epidemic. Clin Infect Dis 2004, 38:890-894
13. Shoptaw S, Reback CJ, Freese TE: Patient characteristics, HIV serostatus, and risk behaviors among gay and bisexual males seeking treatment for methamphetamine abuse and dependence in Los Angeles. J Addict Dis 2002, 21:91-105
14. Ellis RJ, Childers ME, Cherner M, Lazzaretto D, Letendre S, Grant I: Increased human immunodeficiency virus loads in active methamphetamine users are explained by reduced effectiveness of antiretroviral therapy. J Infect Dis 2003, 188:1820-1826
15. Gavrilin MA, Mathes LE, Podell M: Methamphetamine enhances cell-associated feline immunodeficiency virus replication in astrocytes. J Neurovirol 2002, 8:240-249
16. Kopnisky KL, Bao J, Lin YW: Neurobiology of HIV, psychiatric and substance abuse comorbidity research: workshop report. Brain Behav Immun 2007, 21:428-441
17. Berman JW, Berman MJ, Masliah E, Chang L, Cox BW, Fox H, Gonzalez RG, Hanson GR, Hauser KF, Ho WZ, Hong JS, Major EO, Maragos W, Masliah E, McArthur JC, Miller DB, Nath A, O'Callaghan JP, Persidsky Y, Power C, Rogers TJ, Royal W III: NeuroAIDS, drug abuse, and inflammation: building collaborative research activities. J Neuroimmune Pharmacol 2006, 1:351-399
18. Embretson J, Zupancic M, Beneke J, Till M, Wolinsky S, Ribas JL, Burke A, Haase AT: Analysis of human immunodeficiency virus-infected tissues by amplification and in situ hybridization reveals latent and permissive infections at single-cell resolution. Proc Natl Acad Sci USA 1993, 90:357-361
19. Embretson J, Zupancic M, Ribas JL, Burke A, Racz P, Tenner-Racz K, Haase AT: Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 1993, 362:359-362
20. Guo CJ, Li Y, Tian S, Wang X, Douglas SD, Ho WZ: Morphine enhances HIV infection of human blood mononuclear phagocytes through modulation of beta-chemokines and CCR5 receptor. J Investig Med 2002, 50:435-442
21. Hu S, Chao CC, Hegg CC, Thayer S, Peterson PK: Morphine inhibits human microglial cell production of, and migration towards RANTES. J Psychopharmacol 2000, 14:238-243
22. In SW, Son EW, Rhee DK, Pyo S: Modulation of murine macrophage function by methamphetamine. J Toxicol Environ Health A 2004, 67:1923-1937
23. Mahajan SD, Hu Z, Reynolds JL, Aalinkeel R, Schwartz SA, Nair MP: Methamphetamine modulates gene expression patterns in monocyte derived mature dendritic cells: implications for HIV-1 pathogenesis. Mol Diagn Ther 2006, 10:257-269
24. Reynolds JL, Mahajan SD, Sykes DE, Schwartz SA, Nair MP: Proteomic analyses of methamphetamine (METH)-induced differential protein expression by immature dendritic cells (IDC). Biochim Biophys Acta 2007, 1774:433-442
25. Hassan NF, Campbell DE, Douglas SD: Purification of human monocytes on gelatin-coated surfaces. J Immunol Methods 1986, 95:273-276
26. Gjerde H, Hasvold I, Pettersen G, Christophersen AS: Determination of amphetamine and methamphetamine in blood by derivatization with perfluorooctanoyl chloride and gas chromatography/mass spectrometry. J Anal Toxicol 1993, 17:65-68
27. Melega WP, Cho AK, Harvey D, Lacan G: Methamphetamine blood concentrations in human abusers: application to pharmacokinetic modeling. Synapse 2007, 61:216-220
28. Schepers RJ, Oyler JM, Joseph RE Jr, Cone EJ, Moolchan ET, Huestis MA: Methamphetamine and amphetamine pharmacokinetics in oral fluid and plasma after controlled oral methamphetamine administration to human volunteers. Clin Chem 2003, 49:121-132
29. Takayasu T, Ohshima T, Nishigami J, Kondo T, Nagano T: Screening and determination of methamphetamine and amphetamine in the blood, urine and stomach contents in emergency medical care and autopsy cases. J Clin Forensic Med 1995, 2:25-33
30. Ho WZ, Lioy J, Song L, Cutilli JR, Polin RA, Douglas SD: Infection of cord blood monocyte-derived macrophages with human immunodeficiency virus type 1. J Virol 1992, 66:573-579
31. Li Y, Zhang T, Douglas SD, Lai JP, Xiao WD, Pleasure DE, Ho WZ: Morphine enhances hepatitis C virus (HCV) replicon expression. Am J Pathol 2003, 163:1167-1175
32. Zhang T, Lin RT, Li Y, Douglas SD, Maxcey C, Ho C, Lai JP, Wang YJ, Wan Q, Ho WZ: Hepatitis C virus inhibits intracellular interferon alpha expression in human hepatic cell lines. Hepatology 2005, 42:819-827
33. Ostadali MR, Ahangari G, Eslami MB, Razavi A, Zarrindast MR, Ahmadkhaniha HR, Boulhari J: The detection of dopamine gene receptors (DRD1-DRD5) expression on human peripheral blood lymphocytes by real time PCR. Iran J Allergy Asthma Immunol 2004, 3:169-174
34. Deng H, Liu R, Ellmeier W, Choe S, Unutmaz D, Burkhart M, Di Marzio P, Marmon S, Sutton RE, Hill CM, Davis CB, Peiper SC, Schall TJ, Littman DR, Landau NR: Identification of a major co-receptor for primary isolates of HIV-1. Nature 1996, 381:661-666
35. Samuel CE: Antiviral actions of interferons. Clin Microbiol Rev 2001, 14:778-809
36. Baca-Regen L, Heinzinger N, Stevenson M, Gendelman HE: Alpha interferon-induced antiretroviral activities: restriction of viral nucleic acid synthesis and progeny virion production in human immunodeficiency virus type 1-infected monocytes. J Virol 1994, 68:7559-7565
37. Meylan PR, Guatelli JC, Munis JR, Richman DD, Kornbluth RS: Mechanisms for the inhibition of HIV replication by interferons-alpha, -beta, and -gamma in primary human macrophages. Virology 1993, 193:138-148
38. Darnell JE Jr: STATs and gene regulation. Science 1997, 277:1630-1635
39. Darnell JE Jr, Kerr IM, Stark GR: Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994, 264:1415-1421
40. Garofalo R, Mustanski BS, McKirnan DJ, Herrick A, Donenberg GR: Methamphetamine and young men who have sex with men: understanding patterns and correlates of use and the association with HIV-related sexual risk. Arch Pediatr Adolesc Med 2007, 161:591-596
41. Riddle EL, Fleckenstein AE, Hanson GR: Mechanisms of methamphetamine- induced dopaminergic neurotoxicity. AAPS J 2006, 8:E413-E418
42. Yamagata K, Suzuki K, Sugiura H, Kawashima N, Okuyama S: Activation of an effector immediate-early gene arc by methamphetamine. Ann NY Acad Sci 2000, 914:22-32
43. Nair MPN, Mahajan SD, Syes D, Bapardekar MV, Reynolds JL: Methamphetamine modulates DC-SIGN expression by mature dendritic cells. J Neuroimmune Pharmacol 2006, 1:296-304
44. Worsley JN, Moszczynska A, Falardeau P, Kalasinsky KS, Schmunk G, Guttman M, Furukawa Y, Ang L, Adams V, Reiber G, Anthony RA, Wickham D, Kish SJ: Dopamine D1 receptor protein is elevated in nucleus accumbens of human, chronic methamphetamine users. Mol Psychiatry 2000, 5:664-672
45. Rohr O, Sawaya BE, Lecestre D, Aunis D, Schaeffer E: Dopamine stimulates expression of the human immunodeficiency virus type 1 via NF-kappaB in cells of the immune system. Nucleic Acids Res 1999, 27:3291-3299
46. Scheller C, Sopper S, Jassoy C, ter Meulen V, Riederer P, Koutsilieri E: Dopamine activates HIV in chronically infected T lymphoblasts. J Neural Transm 2000, 107:1483-1489
47. Brown SW, Meyers RT, Brennan KM, Rumble JM, Narasimhachari N, Perozzi EF, Ryan JJ, Stewart JK, Fischer-Stenger K: Catecholamines in a macrophage cell line. J Neuroimmunol 2003, 135:47-55
48. Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, Berger EA: CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996, 272:1955-1958
49. Dragic T, Litwin V, Allaway GP, Martin SR, Huang Y, Nagashima KA, Cayanan C, Maddon PJ, Koup RA, Moore JP, Paxton WA: HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996, 381:667-673
50. House RV, Thomas PT, Bhargava HN: Comparison of immune functional parameters following in vitro exposure to natural and synthetic amphetamines. Immunopharmacol Immunotoxicol 1994, 16:1-21
51. Yu Q, Zhang D, Walston M, Zhang J, Liu Y, Watson RR: Chronic methamphetamine exposure alters immune function in normal and retrovirus-infected mice. Int Immunopharmacol 2002, 2:951-962
52. Poli G, Vicenzi E, Ghezzi S, Lazzarin A: Cytokines in the acquired immunodeficiency syndrome and other infectious diseases. Int J Clin Lab Res 1995, 25:128-134
53. Mbow ML, Sarisky RT: What is disrupting IFN-alpha's antiviral activity? Trends Biotechnol 2004, 22:395-399
54. O'Shea JJ, Gadina M, Schreiber RD: Cytokine signaling in 2002: new surprises in the Jak/Stat pathway. Cell 2002, 109(Suppl):S121-S131
55. van Boxel-Dezaire AH, Rani MR, Stark GR: Complex modulation of cell type-specific signaling in response to type I interferons. Immunity 2006, 25:361-372